Caprock Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Caprock Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$606K	Hold	4,741	–	–	0.01%	686
2025 Q4	$578K	Sell	4,741 -569	-11%	-$65.2K	0.01%	767
2025 Q3	$477K	Buy	+5,310	New	+$478K	0.01%	822
2025 Q1	$313K	Hold	3,853	–	–	0.01%	855
2024 Q4	$347K	Hold	3,853	–	–	0.01%	748
2024 Q3	$381K	Sell	3,853 -1	-0%	-$98	0.01%	645
2024 Q2	$357K	Sell	3,854 -597	-13%	-$53.5K	0.01%	635
2024 Q1	$422K	Hold	4,451	–	–	0.02%	461
2023 Q4	$398K	Sell	4,451 -1,340	-23%	-$99.5K	0.03%	459
2023 Q3	$423K	Sell	5,791 -3,052	-35%	-$244K	0.03%	399
2023 Q2	$736K	Buy	8,843 +1,155	+15%	+$96.6K	0.05%	274
2023 Q1	$586K	Buy	7,688 +62	+0.8%	+$5.14K	0.05%	325
2022 Q4	$633K	Buy	7,626 +660	+9%	+$53.4K	0.06%	241
2022 Q3	$553K	Buy	6,966 +476	+7%	+$40.1K	0.05%	258
2022 Q2	$482K	Buy	+6,490	New	+$487K	0.05%	273

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Caprock Group's XBI Position: Q1 2026 in Review

Caprock Group held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q1 2026 at 4,741 shares worth $606K. The position accounts for 0.01% of the portfolio, ranked #686.

Caprock Group first reported a position in XBI in Q2 2022 and has held it in 15 quarters since. The position peaked at $736K in Q2 2023. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

Caprock Group held 4,741 shares of State Street SPDR S&P Biotech ETF worth $606K as of Q1 2026.
Caprock Group left its State Street SPDR S&P Biotech ETF share count unchanged in Q1 2026.
State Street SPDR S&P Biotech ETF made up 0.01% of Caprock Group's portfolio in Q1 2026, its #686 holding.
Caprock Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 15 quarters since.
Caprock Group's State Street SPDR S&P Biotech ETF position peaked at $736K in Q2 2023.
813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Caprock Group's 13F filing for Q1 2026, filed 11 May 2026.